Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
2 Bargain Stocks You Can Buy Today and Hold Forever
05:52am, Tuesday, 13'th Jun 2023
Bank of America remains financially strong and is a leading technology innovator. Pfizer's new products and business development deals give it solid growth drivers.
Stability Meets Growth: 3 Undervalued Blue-Chip Stock Picks
02:06pm, Monday, 12'th Jun 2023
It's starting to get a little frothy out there. Many speculative stocks are shooting up.
Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now?
10:13am, Monday, 12'th Jun 2023
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
7 Top Blue-Chip Stocks to Buy in June 2023
04:25pm, Sunday, 11'th Jun 2023
The market probably feels like the movie Groundhog's Day for many investors. The major indexes continue to trade within a range, which is frustrating both bulls and bears.
5 Relatively Safe And Cheap Dividend Stocks To Invest In - June 2023
09:30am, Saturday, 10'th Jun 2023
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying and are offering large discounts to their historical norms. We go over
3 No-Brainer Stocks to Buy in June
06:14am, Saturday, 10'th Jun 2023
Axsome Therapeutics is a rising star in biotech. Pfizer is too cheap to pass up.
The Top Healthcare Stocks to Buy With $100
02:00pm, Friday, 09'th Jun 2023
Teladoc and Axsome offer solid growth potential and are in the early days of their growth stories. Pfizer offers passive income while investors wait for this pharma-giant's new phase of growth to begi
Pfizer Or Gilead Sciences? Let's Ask Peter Lynch
09:45pm, Thursday, 08'th Jun 2023
Peter Lynch is often not considered a dividend investor, which is unfortunate. He has so many valuable insights into dividend stocks that can benefit us. It's just his success with 10-baggers has domi
GSK's RSV Vaccine Arexvy Gets EU Approval for Older Adults
02:34pm, Wednesday, 07'th Jun 2023
The approval of GSK's RSV vaccine for older adults is based on positive data from the pivotal AReSVi-006 phase III study.
2 Unstoppable Stocks to Buy Before the Bull Market
07:15am, Wednesday, 07'th Jun 2023
Demand for Palantir's products is through the roof as AI unlocks a huge new growth catalyst. Pfizer has been on an acquisition spree over the past few years as it looks to grow and diversify.
Moderna, Pfizer hit with new patent lawsuits over COVID vaccines
05:16pm, Tuesday, 06'th Jun 2023
Biotech firm Promosome LLC sued Moderna , Pfizer and BioNTech , in federal court in San Diego, California, on Tuesday, accusing their COVID-19 vaccines of infringing a patent related to messenger RNA
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Tuesday, 06'th Jun 2023
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with William Pao, Chief Development Officer, Executive Vice
2 Blue-Chip REITs At Big Discounts
08:05am, Monday, 05'th Jun 2023
Real estate is the worst-performing sector of the stock market over the last year as the market has shunned REITs. Over the long term, however, REITs have consistently been strong performers. As REITs
Could Pfizer Have an Ozempic Killer on the Way?
05:55am, Monday, 05'th Jun 2023
Pfizer's danuglipron could have a key competitive advantage over Ozempic. However, it will be a while before the drug could make it to market.
Looking for Passive Income at a Decent Price? Buy These 2 Stocks
05:05am, Monday, 05'th Jun 2023
High-quality dividend stocks typically aren't cheap. Viatris has a great roster of medicines on the market, with more generics to come.
